In March, Suomi.fi e-authorisations will be taken into use in the e-Service of the Pharmaceuticals Pricing Board. The introduction is planned for week 12. Due to the introduction of the new service, the e-Service of the Pharmaceuticals Pricing Board will have interruptions on weeks 11 and 12. We will provide detailed information on downtime in March.
In Suomi-fi services, companies can already grant persons or other companies mandates, i.e. the right to act on behalf of the assignor company (principal). There are two mandate alternatives for the services provided by the Pharmaceuticals Pricing Board. A mandate gives access to all pending cases of the company, or to matters brought by the authorised party only. See a more detailed description of these alternatives below.
To request a mandate, please contact the person in charge of your company’s Suomi.fi service. Alternatively, you can make your request in the Suomi.fi service (https://www.suomi.fi/e-authorizations). Be sure to provide either an extensive or limited specifier for your mandate theme. Type the specifier in small letters. If there is no specifier or its spelling is incorrect, your access to the Pharmaceuticals Pricing Board’s e-service will be prevented.
The use of the e-Service requires that the person or company have been granted either a mandate for transactions or a mandate to represent as well as a mandate theme and a mandate specifier in the Suomi.fi e-authorisation system.
When granting a mandate for the Pharmaceuticals Pricing Board’s e-service,
◦ choose a mandate type, either mandate for transactions or mandate to represent
◦ mandate theme shall be applying for reimbursability and a wholesale price for medicines
◦ mandate specifier can be limited or extensive.
A person or a company with a mandate for transactions can act on behalf of the assignor company (principal). For example, a company may grant its employee or another company (such as a consulting company) the right to act on its behalf.
A person who has been granted a mandate to represent may act on behalf of the assignor company that has granted your company the right to represent them. For example, a consulting company may grant its employee the right to act on behalf of their customer company.
A combination of the mandate theme “applying for reimbursability and a wholesale price for medicines” and a limited mandate specifier entitles to submit applications for reimbursement and wholesale price via the Pharmaceuticals Pricing Board’s online services, to monitor the progress of the applications and to submit additional information. The mandate only gives access to matters initiated by the user in question. The mandate corresponds to the role of “Hila Applicant, limited” that was previously used.
A combination of the mandate theme “applying for reimbursability and a wholesale price for medicines” and an extensive mandate specifier entitles to submit applications for reimbursement and wholesale price via the Pharmaceuticals Pricing Board’s online services, to monitor the progress of the applications and to submit additional information. The mandate gives access to all matters dealt with by the company in the e-Service. The mandate corresponds to the previously used role of “Hila Applicant, large”.
See also the instructions of the Digital and Population Data Services Agency.
◦ Request a mandate for transactions as a person
◦ Acting on behalf of a company or an organisation
◦ Grant a mandate as a company or an organisation
◦ Request a mandate as a company or an organisation
◦ Frequently asked questions on e-Authorizations
◦ Suomi.fi e-Authorizations video and PDF instructions
◦ Glossary of e-Authorizations
Inquiries
Ulla Kurkijärvi, Principal Pharmaceutical Officer, tel. +358 295 163 436
Karoliina Ahponen, Pharmaceutical Officer, tel. +358 295 163 443
firstname.lastname@stm.fi